Zai Lab Ltd/ US98887Q1040 /
2024-06-27 10:00:00 PM | Chg. -0.4500 | Volume | Bid1:37:33 AM | Ask1:37:33 AM | High | Low |
---|---|---|---|---|---|---|
17.5200USD | -2.50% | 485,499 Turnover: 6.72 mill. |
17.2800Bid Size: 100 | 17.7000Ask Size: 100 | 17.9000 | 17.1200 |
GlobeNewswire
06-01
Cullinan Therapeutics Announces Positive Initial Data from Pivotal Phase 2b REZILIENT1 Study of Zipa...
GlobeNewswire
05-09
argenx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
04-18
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated P...
GlobeNewswire
04-10
Crescendo Biologics presents preclinical data on lead clinical candidate CB307 and unveils its first...
GlobeNewswire
03-05
Paratek Pharmaceuticals Announces Positive Efficacy Data for NUZYRA® as Post-Exposure Prophylaxis of...
GlobeNewswire
02-29
argenx Reports Full Year 2023 Financial Results and Provides Fourth Quarter Business Update
GlobeNewswire
01-16
Paratek Pharmaceuticals Announces Promotion of Jonathan Light to General Counsel, Corporate Secretar...
GlobeNewswire
2023-12-13
Paratek Pharmaceuticals Announces Inclusion of Oral NUZYRA® in China’s National Reimbursement Drug L...
GlobeNewswire
2023-12-06
Crescendo Biologics announces first U.S. patients dosed in expanded Phase 1b clinical trial of CB307...
GlobeNewswire
2023-11-07
Zai Lab Announces Third Quarter 2023 Financial Results and Recent Corporate Updates
GlobeNewswire
2023-10-31
argenx Reports Third Quarter 2023 Financial Results and Provides Business Update
GlobeNewswire
2023-10-18
Zai Lab to Announce Third Quarter 2023 Financial Results and Recent Corporate Updates on November 7,...
GlobeNewswire
2023-09-21
Gurnet Point Capital and Novo Holdings A/S Complete Acquisition of Paratek Pharmaceuticals, Inc.
GlobeNewswire
2023-09-18
Paratek Pharmaceuticals Announces Stockholder Approval of Acquisition by Gurnet Point Capital and No...
GlobeNewswire
2023-09-18
Zai Lab Obtains Breakthrough Therapy Designation for Efgartigimod Alfa Injection (Subcutaneous Injec...
GlobeNewswire
2023-09-12
Second Leading Independent Proxy Advisory Firm Glass Lewis Recommends Paratek Pharmaceuticals Stockh...
GlobeNewswire
2023-09-07
Leading Independent Proxy Advisory Firm ISS Recommends Paratek Pharmaceuticals Stockholders Vote FOR...